Keyphrases
Apoptosis
100%
B-cell Lymphoma 2 (Bcl-2)
33%
BCL2L1
33%
BIRC5
33%
CDK4 Inhibitors
33%
Co-target
33%
Combinational Therapy
33%
Cyclin-dependent Kinase 4 (CDK4)
100%
Deregulation
33%
Dual Inhibition
100%
ERK Pathway
33%
Human Melanoma Cells
100%
MEK Inhibitor (MEKi)
33%
MEK-ERK
33%
Melanoma Development
33%
Melanoma Treatment
33%
Monotherapy
33%
P16INK4a
33%
PD98059
33%
Promising Strategies
33%
RB Pathway
66%
Immunology and Microbiology
Downregulation
100%
Melanoma Cell
100%
Melanoma Cell Line
100%
Upregulation
100%
Pharmacology, Toxicology and Pharmaceutical Science
2 (2 Amino 3 Methoxyphenyl)chromone
25%
Clinical Study
25%
Melanoma
100%
Mitogen Activated Protein Kinase Kinase Inhibitor
25%
Monotherapy
25%